ArticleEndocrine-related cancer2014

TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.

Garrett Daniels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.